Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric cancer.

Vincenzo Catalano1, Roberto Labianca, Giordano D Beretta

  • 1Azienda Ospedaliera Ospedale San Salvatore, Pesaro, Italy. catalano_v@yahoo.it

Critical Reviews in Oncology/Hematology
|May 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of older adults with colorectal cancer - The state-of-the-art in 2026.

Journal of geriatric oncology·2026
Same author

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 study.

Investigational new drugs·2026
Same author

Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients.

European journal of nuclear medicine and molecular imaging·2026
Same author

Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Young onset rectal cancer (YORC): a descriptive tertiary center analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

Estrobolome and the Endocrine-Microbiome Axis in Breast and Endometrial Carcinogenesis.

Critical reviews in oncology/hematology·2026
Same journal

Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy.

Critical reviews in oncology/hematology·2026
Same journal

Neoadjuvant immunotherapy in melanoma: From pathologic response to response-adapted management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: Implications for tumor biology and therapeutic strategies - A comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
See all related articles

Gastric cancer remains a leading cause of cancer death, with poor prognosis in advanced stages. Despite treatment advances, survival benefits from new therapies are limited, highlighting the need for updated management guidelines.

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Oncology

Background:

  • Gastric cancer is a significant global health challenge, ranking among the most common cancers and a leading cause of cancer-related mortality.
  • Despite recent advancements in incidence, diagnostics, and therapeutics, patient prognosis, particularly in advanced stages, remains unfavorable.
  • Surgery is the primary treatment modality, yet it is frequently followed by locoregional and distant recurrence, underscoring the need for effective adjuvant strategies.

Purpose of the Study:

  • To review and summarize current, evidence-based recommendations for the comprehensive management of gastric cancer patients.
  • To address the ongoing debate surrounding adjuvant treatment efficacy in advanced gastric cancer.
  • To provide an overview of therapeutic options and their outcomes in clinical trials.

Related Experiment Videos

Main Methods:

  • Systematic review of recent literature and phase III clinical trials.
  • Analysis of diagnostic modalities and surgical techniques.
  • Evaluation of systemic therapies, including combination treatments and adjuvant approaches.

Main Results:

  • Surgical resection remains the cornerstone of gastric cancer treatment.
  • Adjuvant treatment strategies are under continuous investigation, with limited demonstrated survival advantages in many phase III trials.
  • Palliative care is a primary goal in advanced disease management, focusing on symptom control rather than cure.

Conclusions:

  • Optimal management of gastric cancer requires a multidisciplinary approach, integrating surgery, and consideration of systemic therapies.
  • Further research is crucial to improve survival outcomes, particularly for patients with advanced or recurrent disease.
  • Updated clinical guidelines are essential to guide healthcare professionals in providing the best possible care for gastric cancer patients.